David D. O'Toole
Net Worth

Last updated:

What is David D. O'Toole net worth?

The estimated net worth of Mr. David D. O'Toole is at least $4,406,180 as of 27 Jan 2023. He has earned $73,530 from insider trading and has received compensation worth at least $4,332,650 in Opiant Pharmaceuticals, Inc..

What is the salary of David D. O'Toole?

Mr. David D. O'Toole salary is $618,950 per year as Chief Financial Officer in Opiant Pharmaceuticals, Inc..

How old is David D. O'Toole?

Mr. David D. O'Toole is 66 years old, born in 1959.

What stocks does David D. O'Toole currently own?

As insider, Mr. David D. O'Toole owns shares in one company:

Company Title Shares Price per share Total value
Opiant Pharmaceuticals, Inc. (OPNT) Chief Financial Officer 34,248 $0 $0

What does Opiant Pharmaceuticals, Inc. do?

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.

OPNT logo
OPNT
Opiant Pharmaceuticals, Inc.

David D. O'Toole insider trading

Opiant Pharmaceuticals, Inc.

Mr. David D. O'Toole has made 5 insider trades between 2018-2023, according to the Form 4 filled with the SEC. Most recently he sold 541 units of OPNT stock worth $10,961 on 27 Jan 2023.

The largest trade he's ever made was exercising 3,000 units of OPNT stock on 11 May 2018. As of 27 Jan 2023 he still owns at least 34,248 units of OPNT stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 541 $20.26 $10,961
Sale
Common Stock 415 $20.2 $8,383
Sale
Common Stock 1,600 $20.2 $32,320
Sale
Common Stock 779 $11.1 $8,647
Sale
Common Stock 432 $30.6 $13,219
Purchase
Common Stock 200 $19.09 $3,818
Purchase
Common Stock 600 $15.38 $9,228
Purchase
Common Stock 1,000 $8.74 $8,740
Purchase
Common Stock 1,000 $11 $11,000
Purchase
Common Stock 100 $13.22 $1,322
Purchase
Common Stock 1,100 $7.5 $8,250
Purchase
Common Stock 1,000 N/A N/A
Purchase
Common Stock 1,000 N/A N/A
Purchase
Common Stock 1,015 N/A N/A
Purchase
Common Stock 2,000 N/A N/A
Purchase
Common Stock 3,000 N/A N/A

Opiant Pharmaceuticals key executives

Opiant Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: